reduce or eliminate thimerosal as a preservative in pediatric vaccines

Manufacturers are being urged to reduce or eliminate thimerosal as a preservative in pediatric vaccines.

The concern is that the cumulative amount of mercury from thimerosal could exceed safe limits in young infants.

Currently, infants get up to 12 shots in their first 6 months.

Get concise, unbiased advice for effective drug therapy, plus CE/CME

Prescriber Insights: APRN includes:

  • Cutting-edge advice about new medications and how they fit into practice
  • Unbiased, evidence-based, 100% free of financial support from the pharma industry written by your peers
  • Side-by-side comparisons of drugs by class or disease state, plus FAQs, pros/cons, and simple recommendations

Already a subscriber? Log in

Volume pricing available. Get a quote